These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19435978)

  • 1. Adenine phosphoribosyltransferase deficiency in a Chinese man with early-onset gout.
    Chen CJ; Schumacher HR
    J Rheumatol; 2009 May; 36(5):1090-1. PubMed ID: 19435978
    [No Abstract]   [Full Text] [Related]  

  • 2. A retrospective investigation of HLA-B*5801 in hyperuricemia patients in a Han population of China.
    Cheng H; Yan D; Zuo X; Liu J; Liu W; Zhang Y
    Pharmacogenet Genomics; 2018 May; 28(5):117-124. PubMed ID: 29642234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adenine phosphoribosyltransferase deficiency].
    Kamatani N
    Nihon Rinsho; 1993 Jan; 51 Suppl():1087-95. PubMed ID: 8459532
    [No Abstract]   [Full Text] [Related]  

  • 4. Is HLA-B*58:01 genotyping cost effective in guiding allopurinol use in gout patients with chronic kidney disease?
    Teng GG; Tan-Koi WC; Dong D; Sung C
    Pharmacogenomics; 2020 Mar; 21(4):279-291. PubMed ID: 32180492
    [No Abstract]   [Full Text] [Related]  

  • 5. [Juvenile gout].
    Carcassi A
    Reumatismo; 1977; 29(2-3):96-100. PubMed ID: 212803
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness analysis of genotyping for HLA-B*5801 and an enhanced safety program in gout patients starting allopurinol in Singapore.
    Dong D; Tan-Koi WC; Teng GG; Finkelstein E; Sung C
    Pharmacogenomics; 2015 Nov; 16(16):1781-93. PubMed ID: 26554739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic advances in gout: potential applications in clinical practice.
    Tai V; Merriman TR; Dalbeth N
    Curr Opin Rheumatol; 2019 Mar; 31(2):144-151. PubMed ID: 30575597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of a novel mutation in APRT heterozygotes.
    Sahota A; Bye S; Chen J; Khattar NH; Turker MS; Moro F; Simmonds HA; Emmerson BT; Gordon RB; Tischfield JA
    Adv Exp Med Biol; 1994; 370():675-8. PubMed ID: 7660994
    [No Abstract]   [Full Text] [Related]  

  • 9. [Allopurinol efficacy in patients with tophus gout and chronic renal failure].
    Iakunina IA; Barskova VG; Nasonova VA
    Ter Arkh; 2006; 78(6):88-91. PubMed ID: 16881370
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness analysis of HLA-B5801 genotyping in the treatment of gout patients with chronic renal insufficiency in Korea.
    Park DJ; Kang JH; Lee JW; Lee KE; Wen L; Kim TJ; Park YW; Park SH; Lee SS
    Arthritis Care Res (Hoboken); 2015 Feb; 67(2):280-7. PubMed ID: 25047754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adenine phosphoribosyltransferase (APRT) deficiency].
    Taniguchi A
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):464-6. PubMed ID: 9590102
    [No Abstract]   [Full Text] [Related]  

  • 12. Gout: its causes, symptoms and treatment.
    Hill J
    Nurs Times; 1999 Nov 24-Dec 1; 95(47):48-50. PubMed ID: 11096905
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of a new single-nucleotide mutation on the hypoxanthine-guanine phosphoribosyltransferase gene from 983 cases with gout in Taiwan.
    Wu CH; Lai HM; Yang MC; Liaw CC; Chang SJ; Ko YC; Chen CJ
    J Rheumatol; 2007 Apr; 34(4):794-7. PubMed ID: 17309125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febuxostat versus allopurinol for gout.
    Gelber AC
    N Engl J Med; 2006 Apr; 354(14):1532-3; author reply 1532-3. PubMed ID: 16602151
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adenine phosphoribosyltransferase deficiency].
    Kamatani N
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):615-8. PubMed ID: 2908398
    [No Abstract]   [Full Text] [Related]  

  • 16. [2,8-dihydroxyadenine urolithiasis due to partial deficiency of adenine phosphoribosyltransferase: a case report].
    Ohne T; Fujito A; Koga K; Imaide Y; Uchida M
    Hinyokika Kiyo; 1998 Oct; 44(10):725-8. PubMed ID: 9850838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic considerations in the treatment of gout.
    Roberts RL; Stamp LK
    Pharmacogenomics; 2015; 16(6):619-29. PubMed ID: 25876828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gout management: let's get it right this time.
    Sundy JS
    Arthritis Rheum; 2008 Nov; 59(11):1535-7. PubMed ID: 18975368
    [No Abstract]   [Full Text] [Related]  

  • 19. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case 9: initiation of urate-lowering therapy for advanced gout complicated by chronic renal insufficiency.
    Edwards NL
    Am J Med; 2006 Nov; 119(11 Suppl 1):S29-31. PubMed ID: 17059911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.